Jeff Johnson
Stock Analyst at Baird
(4.68)
# 138
Out of 4,840 analysts
140
Total ratings
59.79%
Success rate
30.61%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Upgrades: Outperform | $21 → $23 | $18.03 | +27.57% | 8 | May 27, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $130 → $115 | $93.08 | +23.55% | 14 | May 6, 2025 | |
| DXCM DexCom | Maintains: Outperform | $115 → $105 | $86.82 | +20.94% | 14 | May 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $33 → $24 | $21.41 | +12.10% | 16 | May 1, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $117 → $107 | $80.10 | +33.58% | 16 | Mar 7, 2025 | |
| ALC Alcon | Maintains: Outperform | $104 → $108 | $85.34 | +26.55% | 9 | Feb 27, 2025 | |
| BBNX Beta Bionics | Initiates: Neutral | $20 | $14.50 | +37.93% | 1 | Feb 20, 2025 | |
| SYK Stryker | Maintains: Outperform | $378 → $405 | $381.82 | +6.07% | 11 | Oct 30, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $325 → $276 | $177.54 | +55.46% | 18 | Oct 24, 2024 | |
| HSIC Henry Schein | Maintains: Outperform | $92 → $82 | $73.52 | +11.53% | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $180 → $238 | $323.70 | -26.48% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $70 | $33.01 | +112.06% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $53 → $61 | $14.51 | +320.40% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $67 | $16.32 | +310.67% | 6 | Feb 18, 2022 |
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21 → $23
Current: $18.03
Upside: +27.57%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $130 → $115
Current: $93.08
Upside: +23.55%
DexCom
May 2, 2025
Maintains: Outperform
Price Target: $115 → $105
Current: $86.82
Upside: +20.94%
Tandem Diabetes Care
May 1, 2025
Maintains: Neutral
Price Target: $33 → $24
Current: $21.41
Upside: +12.10%
The Cooper Companies
Mar 7, 2025
Maintains: Outperform
Price Target: $117 → $107
Current: $80.10
Upside: +33.58%
Alcon
Feb 27, 2025
Maintains: Outperform
Price Target: $104 → $108
Current: $85.34
Upside: +26.55%
Beta Bionics
Feb 20, 2025
Initiates: Neutral
Price Target: $20
Current: $14.50
Upside: +37.93%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378 → $405
Current: $381.82
Upside: +6.07%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325 → $276
Current: $177.54
Upside: +55.46%
Henry Schein
Aug 7, 2024
Maintains: Outperform
Price Target: $92 → $82
Current: $73.52
Upside: +11.53%
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $323.70
Upside: -26.48%
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $33.01
Upside: +112.06%
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $14.51
Upside: +320.40%
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $16.32
Upside: +310.67%